These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1875 related items for PubMed ID: 26724797

  • 1. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP.
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [Abstract] [Full Text] [Related]

  • 2. Reduced live-birth rates after IVF/ICSI in women with previous unilateral oophorectomy: results of a multicentre cohort study.
    Lind T, Holte J, Olofsson JI, Hadziosmanovic N, Gudmundsson J, Nedstrand E, Lood M, Berglund L, Rodriguez-Wallberg K.
    Hum Reprod; 2018 Feb 01; 33(2):238-247. PubMed ID: 29211889
    [Abstract] [Full Text] [Related]

  • 3. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M, Bogstad J, Løssl K, Prætorius L, Zedeler A, Bryndorf T, Nilas L, Pinborg A.
    Hum Reprod; 2017 Mar 01; 32(3):556-567. PubMed ID: 28130435
    [Abstract] [Full Text] [Related]

  • 4. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H, Tonch N, Simons AH, van der Veen F, Hoek A, Land JA.
    Hum Reprod; 2013 Dec 01; 28(12):3236-46. PubMed ID: 24166594
    [Abstract] [Full Text] [Related]

  • 5. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China.
    Ji J, Liu Y, Tong XH, Luo L, Ma J, Chen Z.
    Hum Reprod; 2013 Oct 01; 28(10):2728-34. PubMed ID: 23887075
    [Abstract] [Full Text] [Related]

  • 6. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.
    Esteves SC, Yarali H, Vuong LN, Carvalho JF, Özbek İY, Polat M, Le HL, Pham TD, Ho TM, Humaidan P, Alviggi C.
    Hum Reprod; 2021 Jul 19; 36(8):2157-2169. PubMed ID: 34179973
    [Abstract] [Full Text] [Related]

  • 7. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
    Xu B, Geerts D, Hu S, Yue J, Li Z, Zhu G, Jin L.
    Hum Reprod; 2020 Jun 01; 35(6):1306-1318. PubMed ID: 32478400
    [Abstract] [Full Text] [Related]

  • 8. Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
    Bülow NS, Warzecha AK, Nielsen MV, Andersen CY, Holt MD, Petersen MR, Sopa N, Zedeler A, Englund AL, Pinborg A, Grøndahl ML, Skouby SO, Macklon NS.
    Hum Reprod; 2023 Nov 02; 38(11):2154-2165. PubMed ID: 37699851
    [Abstract] [Full Text] [Related]

  • 9. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG, Sfontouris IA, Venetis CA, Lainas GT, Zorzovilis IZ, Tarlatzis BC, Kolibianakis EM.
    Hum Reprod; 2015 Oct 02; 30(10):2321-30. PubMed ID: 26307091
    [Abstract] [Full Text] [Related]

  • 10. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.
    Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B.
    Hum Reprod; 2013 Feb 02; 28(2):442-52. PubMed ID: 23136144
    [Abstract] [Full Text] [Related]

  • 11. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A.
    Hum Reprod; 2016 Jun 02; 31(6):1253-64. PubMed ID: 27060174
    [Abstract] [Full Text] [Related]

  • 12. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
    Wu CX, Zhang T, Shu L, Huang J, Diao FY, Ding W, Gao Y, Wang W, Mao YD, Cui YG, Liu JY.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar 25; 53(3):160-166. PubMed ID: 29609229
    [Abstract] [Full Text] [Related]

  • 13. The effect of type of oral contraceptive pill and duration of use on fresh and cumulative live birth rates in IVF/ICSI cycles.
    Montoya-Botero P, Martinez F, Rodríguez-Purata J, Rodríguez I, Coroleu B, Polyzos NP.
    Hum Reprod; 2020 Apr 28; 35(4):826-836. PubMed ID: 32163564
    [Abstract] [Full Text] [Related]

  • 14. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
    Massin N, Abdennebi I, Porcu-Buisson G, Chevalier N, Descat E, Piétin-Vialle C, Goro S, Brussieux M, Pinto M, Pasquier M, Bry-Gauillard H.
    Hum Reprod; 2023 May 02; 38(5):927-937. PubMed ID: 36864699
    [Abstract] [Full Text] [Related]

  • 15. High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers.
    Munch EM, Sparks AE, Zimmerman MB, Van Voorhis BJ, Duran EH.
    Hum Reprod; 2017 Jul 01; 32(7):1402-1409. PubMed ID: 28472321
    [Abstract] [Full Text] [Related]

  • 16. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis.
    Bosdou JK, Venetis CA, Tarlatzis BC, Grimbizis GF, Kolibianakis EM.
    Hum Reprod; 2019 Mar 01; 34(3):491-505. PubMed ID: 30689865
    [Abstract] [Full Text] [Related]

  • 17. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P, Vuong TNL, Ho NAV, Vaiarelli A, Ho MT, Blockeel C, Camus M, Lam AT, van de Vijver A, Humaidan P, Tournaye H, Polyzos NP.
    Hum Reprod; 2017 Nov 01; 32(11):2225-2233. PubMed ID: 29040589
    [Abstract] [Full Text] [Related]

  • 18. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.
    Oudshoorn SC, van Tilborg TC, Eijkemans MJC, Oosterhuis GJE, Friederich J, van Hooff MHA, van Santbrink EJP, Brinkhuis EA, Smeenk JMJ, Kwee J, de Koning CH, Groen H, Lambalk CB, Mol BWJ, Broekmans FJM, Torrance HL, OPTIMIST study group.
    Hum Reprod; 2017 Dec 01; 32(12):2506-2514. PubMed ID: 29121269
    [Abstract] [Full Text] [Related]

  • 19. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S, Son WY, Gilman A, Younes G, Shavit T, Dahan MH.
    Hum Reprod; 2017 Jan 01; 32(1):119-124. PubMed ID: 27852688
    [Abstract] [Full Text] [Related]

  • 20. Association between the number of oocytes retrieved and cumulative live birth rate in women aged 35-40 years undergoing long GnRH agonist IVF/ICSI cycles.
    Zhou J, Wang B, Hu Y, Sun H.
    Arch Gynecol Obstet; 2017 Nov 01; 296(5):1005-1012. PubMed ID: 28879481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 94.